Upgrading to Outperform: The December 9 Plan Re-Cut Is the Re-Rate Catalyst We Flagged in Q3, Q4 Confirms the Operational Setup, and Two of Three Original Hold-Anchors Are Now Resolved

Rating Action: Upgrading to Outperform

This is the third report in our XOM coverage arc. We initiated at Hold (constructive bias) on Q2 2025, maintained Hold on Q3 2025 with the December 9 corporate plan flagged as the natural re-rate inflection, and we are now upgrading to Outperform on the combination of (a) the Dec 9 plan recut, (b) a clean operational Q4, and (c) two of three original Hold-anchors resolved. The arc walk:

• Q2 2025 (Initiating at Hold, constructive bias). Three Hold-anchors framed the rating: (1) the Stabroek arbitration ruling let Chevron into the block via the Hess transaction, introducing a non-zero contractual-precedent risk; (2) the Baytown low-carbon hydrogen 45V haircut put the project under genuine review with Woods stating "if we can't see an eventual path to a market-driven business, we won't move forward with the project"; (3) Pioneer integration was tracking $2B→$3B/yr synergies but the dilutive-share overhang was still material. Permian was at 1.6 mboed. The operational story was clean but the equity already priced it; the Stabroek + 45V + Pioneer-dilution overhangs argued against an Outperform start.
• Q3 2025 (Maintaining Hold, Dec 9 inflection flagged). Operational execution stepped up materially: Permian to 1.7 mboed (record), Yellowtail four months early, Hammerhead sanctioned, 8 of 10 startups complete, Wood Mackenzie validated the lightweight-proppant uplift, $14.3B cumulative cost takeout. But the chemical trough worsened (-$1.4B YoY drag), Baytown 45V FID still not taken, and the Stabroek precedent question went latent rather than resolved. We held Hold and explicitly conditioned the upgrade on the December 9 corporate plan recutting the FY30 algorithm meaningfully higher with explicit accountability for the >$3B 2026 startup uplift.
• Q4 2025 (Today — Upgrading to Outperform). The Dec 9 plan delivered the recut: +$25B 2030 earnings, +$35B 2030 cash flow, no incremental capital, +17% ROCE, Pioneer synergies doubled to $4B/yr, Permian to 2.5 mboed, $145B cumulative surplus cash through 2030. Q4 then confirmed the operational setup: 1.8 mboed Permian (fresh record), 4.7 mboed full-year (40-year high), all 10 startups delivered, $20B FY buyback retired one-third of Pioneer dilution, $15B cumulative cost takeout. Pioneer integration and Stabroek precedent are now resolved or compressed; the chemical trough is the lone live structural drag and management's Q4 commentary suggests we are at or near the cycle floor. The price judgment that held us at Hold — "the equity already prices the constructive view" — has rolled over because the FY30 framework moved up and the equity has not fully repriced. Upgrading.

What gets us to a more aggressive Outperform stance: (a) Mozambique LNG FID in 2H 2026 at the recut competitive cost basis Woods described; (b) chemicals margin inflection — even a single quarter of QoQ improvement would unlock latent value; (c) hyperscaler data-center CCS contract announcement (Woods: "by year end" target with "very serious substantive conversations" already underway); (d) further Pioneer-synergy revision or further plan recut at the next investor-day. What takes us back to Hold: (a) Brent sustains sub-$55/bbl with dividend-coverage strain; (b) Permian per-well economics on the lightweight-proppant rollout disappoint vs. the third-party validation; (c) ICJ ruling on the Venezuela border dispute goes badly for Guyana, reigniting the Stabroek precedent question. What takes us to Underperform: (a) a fresh negative ruling on the JOA framework with material book-value impact; (b) Pioneer synergies slip back from $4B/yr; (c) chemical trough deepens with no demand offset.

Results vs. Consensus

Q4 2025 was a modest EPS beat on a top-line miss — the third consecutive quarter of that algorithmic shape. The story is now familiar: Permian volume + early-Yellowtail-and-Hammerhead operational throughput + structural cost takeout offsetting softer realizations and a chemical drag that has not yet inflected.

Quality of Beat

• EPS-ex-items: The $0.05 beat ($1.71 vs. $1.66) is fundamentally cost-and-volume, same algorithm as Q2 and Q3. The QoQ step-down in earnings-ex-items from $8.06B (Q3) to $7.3B (Q4) is roughly $0.76B and reflects a combination of (i) softer realizations across crude and chemicals as the macro continued to compress, (ii) higher year-end maintenance and turnaround activity, and (iii) the chemical trough not having inflected. The Permian volume and project-startup uplift continued to underpin earnings power; without those, the QoQ delta would have been materially worse.
• Revenue: The 1.6% top-line miss is consistent with the pattern of the last three quarters. Volumes were a fresh record at the segment level (Permian 1.8, total 4.7 FY); the miss is again a price-deck issue rather than market share or volume. We continue to flag this as an algorithmic feature of consensus modeling vs. realized commodity prices in 2025, not a structural concern.
• Production milestone: 4.7 mboed full-year is the highest annual XOM production in over 40 years — a remarkable framing. The combination of Permian record (1.8 mboed Q4) + Stabroek 875 kboed gross + Hammerhead sanctioned (250 kbd, 2029 first oil) + the eight prior startups delivering full-year contribution is what underwrote it. Management's per-barrel earnings claim — "more than double those in 2019 on a constant price basis" — is the structural-mix-shift result we underwrote at initiation.
• Cost takeout: Cumulative structural cost savings reached approximately $15B since 2019, up from $14.3B at Q3 (i.e., ~$0.7B added in Q4 alone). Per Mikells, "captured savings are greater than all other IOC savings combined over the same period." The flywheel continues to compound at the high end of management's $2-2.5B/yr framing — this is the fifth consecutive year of material cost takeout, which is no longer a one-time efficiency but a structural operating model.
• Capital return: $20B in FY 2025 share repurchases retired roughly one-third of the Pioneer-issued shares. The five-year annualized total shareholder return of 29% leads the sector. Distributions over the same five-year period totaled $150B. We note that the buyback pace was reaffirmed for 2026 "subject to reasonable market conditions" — not a step-up, but a reaffirmation of the run-rate, which removes the buy-the-dip framing in favor of a steady-state capital-return profile.
• Stock reaction: Shares were modestly positive on the print + plan combination. The implication: the equity is starting to price in the Dec 9 plan recut but has not yet fully digested the FY30 algorithmic uplift. The fact that the print itself was clean — revenue light, EPS beat, but no operational miss — reinforces the view that the rating discount has shifted from operational risk to chemical-cycle and sector-multiple compression, both of which are improving rather than worsening.

Segment Performance

Upstream — the franchise asset

Upstream is now firing on all cylinders. FY 2025 production of 4.7 mboed is the highest annual print in over 40 years and reflects the cumulative effect of Pioneer integration, Yellowtail's four-month-early arrival in Q3, and the eight prior 2025 startups delivering against guidance. Q4 Permian was a fresh record at 1.8 mboed, and management's tone on the call — "there is no near-term peak Permian for us" — is the most aggressive long-dated production framing we've heard in the four years we've been tracking the basin.

The lightweight-proppant rollout is now at ~25% of 2025 new wells with a 50% target by end of 2026, and Woods explicitly framed there are 40+ stackable technologies in various stages of testing and deployment. The cube-design + maximum-recovery approach — in management's framing, refusing to optimize for individual-well IRR at the expense of resource recovery — is a long-cycle competitive moat that cube-by-cube produces both better economics and lower per-barrel emissions intensity. Mikells's data point that Permian production is expected to be up roughly 200 kboed YoY in 2026 (i.e., to roughly 2.0 mboed FY) compounds into the 2.5 mboed 2030 target with continued cube cadence.

In Guyana, Stabroek production reached approximately 875 kboed gross in Q4 with the first four FPSOs running roughly 100 kbd above the investment basis — an above-design-intent FPSO conversion result for the fourth time in a row, which now constitutes the operational track record the bull thesis was conditioned on. Woods's framing on the force-majeure portion of the block as awaiting the ICJ ruling and then "force majeure pauses the clock" effectively converts the disputed-acreage issue from a contractual-precedent overhang to an embedded long-dated optionality with no near-term P&L impact.

Energy Products — reliability and cost takeout

Energy Products continues to deliver on the structural margin uplift from the consolidated operations organization — reliability is up, cost is down, and the high-value-product mix continues to expand. The Singapore resid upgrade demonstrated full-capacity catalyst performance in Q4, validating proprietary technology to convert low-value fuel oil into higher-value lubricants and diesel — a textbook example of the molecule-up-the-value-chain strategy.

Chemical Products — the lone live structural drag

Chemical Products remains in trough but management's Q4 framing was notably more constructive than Q3. Woods called it "a tale of two halves" with record demand growth on the demand side and persistent capacity expansion on the supply side. The XOM high-value-product mix continues to deliver above-market per-ton margin and structural cost discipline keeps the segment cash-generative even at trough margins. We do not call a chemicals inflection here — the supply-side absorption is unknowable in timing — but we observe (a) management has stopped calling for a near-term recovery, which is a sign of cycle realism, and (b) the segment is now structurally lower-risk because the cost base has been driven down to a position where even a soft margin environment supports cash generation.

Specialty Products & Low Carbon Solutions — embedded optionality with growing scale

Proxima systems expansion online; capacity tripled in 2025; rebar-based applications scaling across automotive, oil-and-gas pipelines, and even XOM's own internal use cases (a Kearl overpass foundation). The advanced battery anode graphite program is delivering 30% faster charging, up to 3% higher available capacity, and up to 4x battery life in testing — the kind of step-change differentiation that, at scale, would justify a separate sum-of-the-parts framing. Lithium remains in the technology-validation phase. The carbon capture network advanced on the Rose permit, brought the first third-party CCS project online (capable of storing up to 2 million tons per year), and secured the seventh CCS contract — total network now approximately 9 million tons per year of sequestered CO2.

The December 9 Corporate Plan Recut — The Re-Rate Catalyst

The headline elements of the December 9 plan:

• +$25B in incremental earnings by 2030 vs. 2024 baseline, with no incremental capital. The prior plan (December 2024) had framed +$20B; the December 9 update raised this by $5B without any change to the capital framework, implying a pure productivity uplift driven by Permian technology + Pioneer synergy revision + project-startup contribution.
• +$35B in incremental cash flow by 2030 vs. 2024 baseline, with the cumulative surplus cash flow expected to reach approximately $145B over the 2026-2030 plan period at $65 real Brent.
• Return-on-capital-employed target of more than 17% by 2030 — up from the 11% five-year average, implying a meaningful structural lift in capital productivity that, if achieved, would push XOM into a different valuation cohort altogether.
• Pioneer synergies doubled from $2B/yr to $4B/yr. This is the single most important update in the plan from a near-term P&L perspective. The original Pioneer underwriting was $2B; Q3 had telegraphed an upward revision; the December 9 plan formalized it at $4B. This roughly doubles the synergy-NPV contribution to the deal economics.
• Permian 2030 target raised to approximately 2.5 mboed from prior "approximately 2.3 mboed" — with Woods explicitly stating the trajectory extends "well into the next decade" and "well beyond 2030" with continued technology-led cube-design improvements.
• Capital framework: $28-33B annually, 2026-2030. Slightly above the $27-29B 2025 envelope but consistent with prior plan-period guidance — this is not a step-up in capital intensity, it is a slight phasing forward to fund Mozambique and Papua New Guinea LNG FIDs in the plan period without departing from the disciplined-capital posture.
• Mozambique LNG FID telegraphed for 2H 2026 with Woods noting the projects organization used the force-majeure delay productively to drive a more cost-advantaged design than the original.

The plan doesn't read as ambitious; it reads as the codification of execution that has already happened. Yellowtail four months early is in the run-rate. Pioneer synergies are tracking. The Permian technology pipeline has 40+ items in flight. The structural cost takeout has compounded for five consecutive years. The plan recut is, in essence, the consensus catching up to the realized operational record — and that is exactly the kind of plan recut that supports a re-rate.

Key Topics & Management Quotes

Permian: no near-term peak

Woods's framing on the Permian was the most aggressive we've heard in four years of tracking the basin. The lightweight-proppant rollout is running ahead of plan and the 40+ stackable technology pipeline implies the trajectory extends far past the 2.5 mboed 2030 target. On the technology toolkit:

"I would tell you nothing, nothing, everything basically points to, if anything, greater promise. Obviously, we've got to demonstrate that in the field. ... There are other technologies, as we've talked to you about as part of the corporate plan update that frankly hold a lot of potential as well, and we're beginning to kind of feather those in."
— Darren Woods, Chairman & CEO

And on the long-dated trajectory:

"There is no near-term peak Permian for us. Our growth trajectory remains robust, and we expect to exceed 2.5 million oil equivalent barrels a day beyond 2030."
— Darren Woods, Chairman & CEO

Guyana: force majeure pauses the clock

The Q4 commentary on Stabroek — specifically, the disputed-acreage portion under force majeure — was the cleanest read on the Q2 Hold-anchor concern about contractual precedent and JOA-rights interpretation. Woods's framing converts a near-term overhang into a long-dated optionality:

"One of the advantages of force majeure is it pauses the clock. And so we will have an opportunity to do what we need to do in that portion of the block when it's available to us."
— Darren Woods, Chairman & CEO

And on the broader operational result:

"Yellowtail came online ahead of schedule, raising gross production in the fourth quarter to roughly 875,000 barrels per day. Altogether, our first four FPSOs are now producing 100,000 barrels a day above the investment basis, reflecting operational performance to date and the value of this advantaged asset."
— Darren Woods, Chairman & CEO

Hyperscaler CCS — embedded optionality the model gives zero credit to

Woods explicitly flagged the data-center CCS conversation as serious, substantive, and on a near-term decision timeline:

"That unique offering, I think, puts us in a position to have really substantive conversations with some of the hyperscalers. And I would say that today we are engaged in very serious substantive conversations with a number of the hyperscalers. ... My hope is and expectation is we should see that work manifest itself. Hopefully by year end with the project announcement."
— Darren Woods, Chairman & CEO

The combination of (a) Denbury-acquired pipeline network, (b) only-at-scale end-to-end CCS system in North America, and (c) a multi-billion-dollar hyperscaler customer set looking for low-carbon power positions XOM uniquely. We do not give the hyperscaler optionality any value in our base case — consistent with our policy of not crediting unsigned commercial optionality — but a year-end announcement would be a meaningful incremental positive.

ERP / data platform transformation — the under-discussed productivity unlock

The most under-discussed piece of the call was the SAP S/4HANA + single-data-construct + AI overlay transformation that Mikells described. The starting state — "more than 10 ERP systems," "more than 65 million lines of custom code, the highest of any of SAP's customers" — is breathtaking and explains why structural cost takeout has had so much room to run. The end-state of 97% fewer profit centers and 70% fewer cost centers, with a clean upgrade-able platform supporting AI-at-scale, is the kind of multi-year productivity unlock that is genuinely difficult to model but materially compounds the cost-takeout flywheel:

"One data construct for the entire corporation. One data set, one set of nomenclatures. It will be the first time in the history of this company that we can actually tap into everything that we're doing across the company. And when you couple that with the opportunity with AI and the data set that that represents, I don't think there's a there's a company out there that can that can match what we're trying to accomplish here."
— Darren Woods, Chairman & CEO

Chemicals: cycle realism but no inflection call

Management's framing was notably more grounded than Q3. The "tale of two halves" framing — record demand vs. persistent capacity adds — matches our reading of the cycle. We do not call a chemical inflection; we observe that the segment is structurally lower-risk than at Q2 because the cost base supports cash generation even at trough margins.

"From a demand standpoint, I would say continue to see very robust strong demand across the world for the chemical products. The challenge with respect to the margins that are out there is obviously from the supply side of the equation. So despite record levels of demand and very good growth in demand, there continues to be a lot of capacity that comes on that expresses the margin."
— Darren Woods, Chairman & CEO

Analyst Q&A — Themes

The Q4 call had nine analyst questions covering Guyana exploration strategy, Permian volume cadence, portfolio gaps (Libya / Iraq / Venezuela), advantaged-asset philosophy on portfolio refresh, LNG FID cadence (Mozambique, Papua New Guinea), the ERP transformation, divestiture environment, base decline rates, hyperscaler CCS optionality, and the chemicals cycle. Notable themes:

• Devin McDermott (Morgan Stanley) opened with the Guyana exploration / force-majeure question. Woods's response — force majeure pauses the clock, awaiting ICJ ruling on the border dispute, less naval patrols a positive — was the cleanest articulation we've heard of the disputed-acreage optionality and effectively neutralized the Q2 Hold-anchor concern.
• Neil Mehta (Goldman Sachs) asked about Permian volume cadence and the lightweight-proppant rollout. Woods cautioned against extrapolating the Q4 record to a full-year 2026 number ("quarters are a little lumpy") but reaffirmed the FY 2026 Permian step-up of approximately 200 kboed YoY. Mehta is also stepping in as the new XOM CFO — a notable sell-side-to-CFO transition that we expect to be accretive to the IR posture going forward.
• Doug Leggate (Wolfe Research) probed for upside-not-in-the-plan on Libya MOU, Iraq PSC terms, and Venezuela. Woods's response was nuanced: confidence that some of these markets will progress, but not in a timeline that drives near-term P&L. We do not credit any of these in our base case but flag the optionality.
• Bob Brackett (Bernstein Research) asked whether new portfolio additions must be "advantaged assets" or whether the criterion would soften. Woods's framing — advantage derives from what XOM brings to the asset, not the asset itself — is the cleanest articulation of the operating-model philosophy and effectively says: any asset XOM acquires becomes advantaged because of XOM's capabilities, so the criterion is about XOM's value-add not the asset's intrinsic quality.
• Arun Jayaram (JPMorgan) asked about LNG FID cadence on Mozambique and Papua New Guinea. Woods telegraphed Mozambique 2H 2026 FID and confirmed Golden Pass first LNG very early March. Both are positive incremental data points.
• Betty Jiang (Barclays) drew out the ERP / data platform transformation detail. This was the most analytically rich exchange of the call (excerpted in the Key Topics section above) — a multi-year productivity unlock that has not been priced in.
• Steve Richardson (Evercore ISI) asked about the divestiture environment. Woods reaffirmed $25B in divestments since 2019 with continued portfolio high-grading. The sale of the French affiliate closed in 2025 — a continued tailwind to portfolio mix.
• Sam Margolin (Wells Fargo) drew out the cross-segment optionality on Proxima rebar / battery anode graphite / lithium. The model gives zero credit to these embedded option positions; a sum-of-the-parts re-rating that credited even partial optionality value would push fair-value materially higher.
• Jean Ann Salisbury (Bank of America) asked about hyperscaler data-center CCS interest. Woods's response (excerpted above) flagged a year-end project announcement target — a near-term catalyst we will track explicitly.
• Paul Cheng (Scotiabank) asked about base-decline rates in upstream and refining/chemicals available uptime. Woods declined to give a specific decline-rate number ("I don't have a number for that") but framed the structural opportunity to keep changing the slope of the curve via technology — a fair non-answer that reads as honest rather than evasive.
• Biraj Borkhataria (RBC) closed with the chemicals question. Woods's "tale of two halves" framing was the most realistic management chemical-cycle framing we have heard — no recovery-date promise, no green-shoot hand-waving, just an honest articulation of demand strength offset by supply absorption.

CFO transition. Kathy Mikells is retiring after a five-year tenure, replaced by Neil Mehta (returning to XOM after his stint at Goldman Sachs as the senior-cited XOM analyst). Mikells's tenure was characterized by capital-discipline reaffirmation, the Pioneer transaction execution, and the ERP transformation kickoff. The Mehta transition is unusually smooth for a CFO change at a company of XOM's scale — we view this as net-positive for IR continuity given Mehta's deep pre-existing knowledge of both the company and the analyst community.

What They're NOT Saying

• Baytown 45V hydrogen FID. Still no decision, still no formal cancellation. Woods has not repeated the Q2 "won't move forward" conditional on this call — which is mildly constructive, but the silence is conspicuous. We continue to model zero contribution.
• Specific 2026 EPS or earnings guidance. Per XOM convention, no quarterly or full-year guidance is given. The implicit guide is the December 9 plan framework (+$25B/+$35B by 2030 algorithmic trajectory) but no annual cadence was provided.
• Specific buyback pace for 2026. Reaffirmed "measured pace ... subject to reasonable market conditions" but no specific dollar number. We assume the FY 2025 $20B run-rate continues into 2026 absent explicit guidance to the contrary.
• Stabroek precedent ruling commentary. The 2024 arbitration loss to Hess/Chevron was not addressed on the call. We read this as the issue having moved from "live overhang" at Q2 to "settled and absorbed" by Q4 — not a positive update, but no longer a Hold-anchor.
• Chemical inflection date. Management has now stopped guiding to a specific inflection — a sign of cycle realism. We do not model a chemicals inflection in the base case.
• Refined 2026 Permian production guide. Mikells gave a "approximately +200 kboed YoY" frame but no point estimate. Our base case is approximately 2.0 mboed FY 2026.

Market Reaction

Stock reaction on the day was modestly positive on the print + plan combination. The setup was: a clean operational beat, a re-cut FY30 algorithm in early December that the equity had partially digested but not fully repriced, and a $20B FY buyback completion. The implication: the equity is starting to price in the Dec 9 plan recut but has not yet fully digested the FY30 algorithmic uplift — the +$25B incremental earnings and 17%+ ROCE targets, if achieved, would justify a multi-point P/E re-rating that consensus estimates have not yet fully embedded. Five-year annualized total shareholder return of 29% is sector-leading; absent the chemicals trough, Q4 would have been a clean operational beat on every dimension.

Street Perspective

The Street is broadly constructive on XOM at year-end 2025 / early 2026 with the Dec 9 plan having driven sell-side estimate revisions higher across the cohort. The bull case being made on the Street is anchored on: (a) the Pioneer synergy revision to $4B/yr, (b) the 17%+ ROCE target as the structural valuation lever, (c) Permian extension to 2.5 mboed by 2030 with continued technology-led growth thereafter, and (d) the post-2030 cash-flow trajectory at $65 real Brent supporting either continued buyback compounding or further inorganic optionality.

The bear case being made is anchored on: (a) chemicals cycle still in trough with no clear inflection, (b) crude/gas-price exposure caps near-term EPS leverage if 2026 macro stays soft, (c) the integrated-major valuation premium remains rich on near-term consensus, and (d) execution risk on the long-dated 17% ROCE target is non-trivial. Our view is closer to the bull framing on the basis that the operational track record over the last five years strongly supports the Dec 9 plan as a base case rather than a stretch case, and that two of three Q2 Hold-anchors have now resolved or compressed.

Model Implications

This print plus the Dec 9 plan drives several model updates:

• FY 2026 Permian: baseline approximately 2.0 mboed (from 1.7 mboed FY 2025), in line with management's +200 kboed framing, with upside to 2.05-2.1 if the lightweight-proppant uplift compounds faster than the cube cadence.
• FY 2026 total production: approximately 4.85 mboed (from 4.7 mboed FY 2025), reflecting Permian step-up + Stabroek full-year contribution from Yellowtail + early Golden Pass LNG.
• Pioneer synergy run-rate: updated to $4B/yr from prior $2-3B/yr framing, fully embedded into FY 2026 P&L.
• Structural cost takeout: updated to ~$2.0B/yr forward run-rate, in line with the cumulative $15B / 5-year average and management's $2-2.5B/yr framing.
• Buyback pace: $20B/yr 2026 base case, consistent with the FY 2025 actual and the management reaffirmation.
• 2030 framework: updated to reflect the +$25B incremental earnings and +$35B incremental cash flow, with the 17%+ ROCE target as the upper-end-of-the-range valuation peg.
• Chemicals: hold the FY 2026 base case at approximately Q4 2025 run-rate (~$0.5B segment earnings) with no inflection assumed; modest QoQ improvement would be a non-trivial positive surprise.
• Hyperscaler CCS: hold at zero contribution in the base case; year-end project announcement (if it materializes) would be the trigger for an upside-case adjustment.

Thesis Scorecard

Overall: Six of eight bull points are confirmed or strengthened, with two new bull points added (Dec 9 plan recut, hyperscaler CCS optionality). On the bear side, two of the three original Q2 Hold-anchors have resolved (Pioneer synergies, Stabroek precedent compressing) and the third (Baytown 45V) is no longer addressed and is modeled at zero. Chemicals is stabilizing rather than worsening. Refining is improving. The integrated-major premium concern that anchored the Hold rating at Q2 and Q3 has reset because the FY30 algorithm has moved up.

Action: Upgrading to Outperform. The price-to-thesis math now leaves meaningful upside under the base case (Dec 9 plan executed cleanly, Pioneer synergies at $4B/yr, Permian at 2.5 mboed by 2030, 17%+ ROCE), substantial upside under the upside case (chemicals inflection or hyperscaler CCS contract added), and limited downside under stress scenarios (sub-$55 Brent or fresh JOA ruling). We expect XOM to outperform the S&P 500 over the next 12 months.

Upgrade-to-buy triggers (more aggressive Outperform): (a) Mozambique LNG FID announced in 2H 2026 at the recut competitive cost basis; (b) chemicals quarterly margin inflection (single quarter of QoQ improvement); (c) hyperscaler data-center CCS contract announcement (Woods's "by year end" target); (d) Pioneer synergies revised further upward at next investor-day; (e) ICJ ruling on Venezuela border dispute clears the disputed Stabroek acreage for development. Downgrade-to-Hold triggers: (a) Brent sustains sub-$55/bbl with dividend-coverage strain; (b) Permian per-well economics on the lightweight-proppant rollout disappoint vs. the third-party validation; (c) ICJ ruling goes badly for Guyana, reigniting Stabroek precedent question; (d) Pioneer synergies slip back from $4B/yr. Downgrade-to-Underperform triggers: (a) fresh negative JOA ruling with material book-value impact; (b) chemical trough deepens with no demand offset; (c) base decline rate accelerates materially with no technology-offsetting framework. We will revisit on the Q1 2026 print and the Mozambique FID announcement.